Exploitation of the Escherichia coli lac operon promoter for controlled recombinant protein production by Browning, Douglas F et al.
 
 
University of Birmingham
Exploitation of the Escherichia coli lac operon
promoter for controlled recombinant protein
production
Browning, Douglas F; Godfrey, Rita E; Richards, Kirsty L; Robinson, Colin; Busby, Stephen J
W
DOI:
10.1042/BST20190059
License:
None: All rights reserved
Document Version
Peer reviewed version
Citation for published version (Harvard):
Browning, DF, Godfrey, RE, Richards, KL, Robinson, C & Busby, SJW 2019, 'Exploitation of the Escherichia coli
lac operon promoter for controlled recombinant protein production', Biochemical Society Transactions, vol. 47,
no. 2, pp. 755-763. https://doi.org/10.1042/BST20190059
Link to publication on Research at Birmingham portal
Publisher Rights Statement:
Checked for eligibility: 12/04/2019
This document is the accepted manuscript version of a published work that appeared in final form in Biochemical Society Transactions. The
final version of record can be found at:
https://doi.org/10.1042/BST20190059
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 14. Jun. 2020
1 
 
For Biochemical Society Transactions   Edited by DFB (11/03/2019) 1 
 2 
BST-2019-0059C 3 
 4 
 5 
 6 
 7 
 8 
Exploitation of the Escherichia coli lac-operon promoter for 9 
controlled recombinant protein production 10 
 11 
 12 
 13 
Douglas F. Browning1, Rita E. Godfrey1, Kirsty L. Richards2, Colin Robinson2 and 14 
Stephen J. W. Busby1 15 
 
16 
 
17 
1 Institute of Microbiology and Infection, School of Biosciences, University of 18 
Birmingham, Birmingham, B15 2TT, UK. 19 
2 School of Biosciences, University of Kent, Ingram Building, Canterbury CT2 7NJ, 20 
UK 21 
 22 
 23 
 24 
 25 
 26 
Correspondence:  Douglas F. Browning (D.F.Browning@bham.ac.uk)  27 
   Stephen J. W. Busby (S.J.W.Busby@bham.ac.uk) 28 
 29 
Word Count: 2183 in main text 30 
  31 
2 
 
Abstract 32 
The Escherichia coli lac operon promoter is widely used as a tool to control recombinant 33 
protein production in bacteria. Here we give a brief review of how it functions, how it is 34 
regulated, and how, based on this knowledge, a suite of lac promoter derivatives has been 35 
developed to give controlled expression that is suitable for diverse biotechnology 36 
applications.  37 
 38 
Key words: Escherichia coli, bacterial transcription initiation, lac promoter, tac promoter, 39 
Lac repressor, recombinant protein production 40 
 41 
Abbreviations Used: RPP, recombinant protein production; RNAP, RNA polymerase; bp, 42 
base pairs; CRE, Core-recognition element; CRP, cyclic AMP receptor protein; LacI, lactose 43 
operon repressor protein; IPTG, isopropyl β-D-1-thiogalactopyranoside; PAR, promoter 44 
activity rating; GFP, green fluorescent protein; hGH, human growth hormone; Tat, twin 45 
arginine translocon pathway; LB: lysogeny broth; ONPG, o-nitrophenyl-β-D-galactopyranose. 46 
 47 
 48 
Introduction 49 
Most of the recombinant protein production (RPP) systems used for expressing proteins in 50 
bacteria were constructed in the last century [1-4]. High level RPP provided by these 51 
systems enables the synthesis and purification of large amounts of soluble recombinant 52 
protein. However, the expression of difficult protein targets (e.g. membrane proteins or 53 
proteins secreted out of the cytoplasm), using these RPP systems, may be too high for cells 54 
to cope and adequately fold protein, resulting in substantial target degradation or the 55 
production of insoluble aggregates (i.e. inclusion bodies) [5-8]. Many “tricks of the trade” can 56 
be employed to slow down RPP expression and increase the level of soluble product, e.g. 57 
lowering the growth temperature, decreasing the inducer concentration or using a weaker 58 
promoter [6-9]. Although such tinkering can be very successful, determining the correct 59 
combination of refinements can be time-consuming. This can also be very “hit-and-miss”, 60 
being dependent on the particular target protein in question [6, 9], and for some induction 61 
regimes, for example when using low inducer concentrations, only a proportion of the cells in 62 
a culture may in fact express recombinant protein [10-12].  63 
 64 
The E. coli lac operon promoter was one of the first bacterial promoters to be adopted by 65 
biotechnologists for RPP, and it is still used today, especially when Escherichia coli is used 66 
as the host [6]. Here, we give a brief update of our current understanding of transcript 67 
initiation in bacteria, emphasising special features of the lac promoter and its regulation. We 68 
then review how, based on this information, many lac promoter derivatives have now been 69 
engineered in order to facilitate controlled RPP expression and avoid the problems that are 70 
concomitant with high level overexpression. 71 
 72 
Transcript initiation and regulation at the E. coli lac operon promoter 73 
Transcript initiation in bacteria takes place when the multisubunit DNA-dependent RNA 74 
polymerase holoenzyme (RNAP) interacts with a DNA promoter sequence (Figure 1A). In 75 
brief, the RNAP first interacts with double-stranded DNA to form a ‘closed complex’ in which 76 
determinants in different RNAP subunits interact with different promoter sequence elements 77 
(Figure 1B) [13]. Thus a determinant in the RNAP α subunit C-terminal domain interacts with 78 
the promoter UP element, a determinant in Domain 4 of the RNAP σ subunit interacts with 79 
the promoter -35 element, and a determinant in Domain 3 of the RNAP σ subunit interacts 80 
with the extended -10 element (Figure 1B). Following this, Domain 2 of the RNAP σ subunit 81 
drives the local unwinding of 13-15 base pairs (bp) of promoter DNA to form the ‘open 82 
complex’, in which the single-stranded DNA template strand is positioned in the active site of 83 
the RNAP, such that initiation of DNA-templated RNA synthesis can take place (Figure 1C) 84 
[14]. Formation of the initiation-competent ‘open complex’ from the ‘closed complex’ is driven 85 
by further specific interactions between other RNAP determinants and promoter sequences 86 
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[15-17]. Thus, determinants in Domain 2 of the RNAP σ subunit interact with single-stranded 87 
bases of the promoter -10 element and with the promoter discriminator element. These 88 
interactions involve only the non-template strand of the locally unwound segment of 89 
promoter DNA, thereby permitting the single-stranded template strand to access the RNAP 90 
active site. The exact position of the template strand in the active site, and the location of the 91 
downstream junction between single-stranded and double stranded DNA, is set by other 92 
contacts involving amino-acid side-chains of the RNAP β and β’ subunits (which interact with 93 
the promoter Core-recognition element, CRE) (Figure 1C) [16].  94 
 95 
The activity of any bacterial promoter is set by the formation of the ‘closed complex’ and the 96 
ensuing isomerisation to, and escape from, the ‘open complex’, as the RNAP copies the 97 
template strand to elongate its transcript. In the case of the E. coli lac operon promoter, 98 
defects in the UP element, -35 element and extended -10 element hinder ‘closed complex’ 99 
formation but this is remedied by binding of an activatory factor, the cyclic AMP receptor 100 
protein (CRP) to a target sequence centred between bp 61 and 62 (referred to as 101 
position -61.5) upstream of the transcript start (denoted as +1; see Figure 1D) [18, 19]. A 102 
second regulator protein, the lactose operon repressor protein (LacI) binds to a high affinity 103 
target sequence, known as operator O1, centred at position +11 (Figure 1D) [19, 20]. LacI 104 
binding to its target effectively shuts down lac promoter activity, but repression can be 105 
broken by the presence of allolactose (a breakdown product of lactose) or by the sugar 106 
analogue IPTG (isopropyl β-D-1-thiogalactopyranoside), which both bind to the LacI 107 
repressor and cause it to release operator DNA [20]. LacI-dependent repression of the lac 108 
promoter is supported by LacI binding to two secondary weaker operators, O3, located at 109 
position -82 (Figure 1D), and far downstream, O2 [19-23]. Here, we review how the starting 110 
lac promoter has been engineered to make it fit for different biotechnology purposes. We 111 
focus on constructions that release the requirement for CRP, base changes in key promoter 112 
elements, and the exploitation of the O3 operator. 113 
 114 
Activator-independent lac promoter derivatives 115 
Figure 2A illustrates the organisation of the E. coli lac operon promoter, showing key 116 
promoter elements, the DNA site for CRP, and the location of LacI-binding operators, O1 117 
and O3. Figure 2B shows the base sequence of a typical DNA fragment carrying the lac 118 
promoter that might be used in any biotechnology application. The fragment, which carries a 119 
useful restriction site at each end, is denoted lac O3O1. Potentially, regulation by CRP might 120 
be exploitable but, since CRP activity is difficult to control by external cues, many 121 
biotechnology applications that use the lac promoter have sought to eliminate CRP effects 122 
and focussed on regulation by LacI. One way to do this is by the use of the lac UV5 mutant 123 
promoter. This mutant promoter carries a 2 bp change in the promoter -10 hexamer element 124 
that creates a consensus -10 promoter element (Figure 2B) [19, 24]. The alternative is to 125 
replace lac promoter upstream DNA sequences and this has been done in the tac promoter, 126 
which is a chimeric fusion between the upstream elements of the E. coli trp promoter and the 127 
downstream elements of the lacUV5 promoter [1, 2]. Figure 2A illustrates both the lacUV5 128 
and tac promoters, and Figure 2B shows the base sequence of DNA fragments carrying 129 
these promoters. Note that the tac promoter carries consensus -35 and -10 promoters 130 
elements and a single operator for LacI, O1. For E. coli promoters that are dependent on the 131 
housekeeping sigma factor σ70 the optimal spacing between the -35 and -10 promoter 132 
elements is 17 bp and deviation from this leads to a reduction in promoter activity [25, 26]. 133 
Thus, it worth noting that both the tac and lac promoters are in fact suboptimal, having 134 
spacers of 16 and 18 bp, respectively (Figure 2B).   135 
 136 
Figure 3A-C illustrates the results of simple assays to compare the activities of the tac, 137 
lacUV5 and lac promoters. To perform these assays, the tac O1 fragment, the lacUV5 O3O1 138 
fragment and the lac O3O1 fragment were each cloned into a plasmid expression vector 139 
(pRW50) such that the promoters controlled transcription of the gene (lacZ) encoding β-140 
galactosidase [27]. Recombinant plasmids were then transformed into a Δlac E. coli host 141 
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strain and β-galactosidase expression was measured. As expected the hierarchy of 142 
promoter activity was tac > lacUV5 > lac (Figure 3). 143 
 144 
Modulation of promoter activities using upstream lac operator sequences 145 
A key feature of LacI-dependent repression of the E. coli lac promoter is the contribution of 146 
the auxiliary upstream operator, O3, and this has been exploited to tailor promoter activity 147 
levels. Data in Figure 3A illustrate how the introduction of certain lac operator sequences (i.e. 148 
O1 or the high affinity “ideal” lac operator Oid, see Figure 2A [21, 28, 29]) at position -82 of 149 
the tac O1 promoter fragment reduced the high activity of the tac promoter. Thus, expression 150 
from the starting tac O1 promoter fragment and each of the tac O3O1, tac O1O1 and tac 151 
OidO1 derivatives was induced by IPTG but the introduction of the O1 and Oid operator 152 
sequences decreased IPTG-induced expression levels. Similarly, data in Figures 3B and 3C 153 
illustrate how the introduction of higher affinity lac operators into the upstream region of the 154 
lacUV5 promoter (i.e. in the lacUV5 O1O1 and lacUV5 OidO1 promoter fragments) or the lac 155 
promoter (i.e. in the lac O1O1 and lac OidO1 promoter fragments) decreased promoter 156 
activity. 157 
 158 
The power of lac: combinations make anything possible 159 
In addition to controlling promoter activity by upstream-bound LacI, activity can be 160 
modulated by point mutations in different promoter elements. Data in Figure 3D illustrate 161 
how the p34G, p14G, p9A or p8A substitutions (at positions -34, -14, -9 or -8), which make 162 
the -35 element, the extended -10 or the -10 element more similar to the respective 163 
consensus, can be combined with different operator combinations to produce a suite of 164 
IPTG-inducible promoters with a wide range of activities.  165 
 166 
To illustrate the use of these promoters in RPP, we selected a subset of 8 promoters from 167 
the above suite and gave each a promoter activity rating (PAR) value of PAR1 to PAR8 168 
(Figure 4A). Our rationale for this is that, depending on the target protein being expressed, 169 
specific IPTG-induced expression levels could be achieved. To examine this, some of the 170 
promoter constructs were introduced into the low-copy-number vector pTorA-GFP [30] and 171 
the high-copy-number vector pHAK1 [31], using standard techniques [32-34]. For pTorA-172 
GFP derivatives, each PAR promoter drives the expression of a torA-GFP-6his fusion (GFP, 173 
green fluorescent protein), whilst, for pHAK1, each construct expresses a torA-hGH-6his 174 
fusion (hGH, human growth hormone). Note that the torA signal sequence in each case will 175 
direct the recombinant protein to the Tat (twin arginine translocon) system for periplasmic 176 
targeting [7, 30, 31]. Plasmid constructs were transferred into E. coli BL21 cells and RPP 177 
was induced in bacterial cultures by the addition of 1 mM IPTG for 3 hrs [7]. Normalised total 178 
cellular protein from cells, expressing either TorA-GFP-6His or TorA-hGH-6His, were then 179 
analysed by Western blotting. Results in Figures 4B and 4C show that both GFP and hGH 180 
were expressed using the PAR promoter constructs. Note that, in some instances, two 181 
product bands can be observed, in each case the species with the higher molecular weight 182 
still carries the TorA signal sequence, whilst the smaller species has been processed and 183 
lacks the TorA moiety [7, 30, 31, 35]. Importantly, using this expression system, inducible 184 
expression of different target proteins can be set to specific levels when using both low- and 185 
high-copy-number vectors. 186 
 187 
Perspectives  188 
The lac promoter and its derivatives have been widely used to express many recombinant 189 
proteins to high levels in E. coli [1, 2, 7, 36] and many currently used vectors have been 190 
designed to optimise expression. However, there are situations where expression must be 191 
moderated. For example, the secretion of recombinant biopharmaceuticals out of the E. coli 192 
cytoplasm into the periplasm is often a preferred industrial strategy, as this minimises 193 
downstream processing costs, since the target protein can be purified from the periplasmic 194 
contents, with minimal cellular and DNA contamination [37]. For this to be successful, RPP 195 
needs to be slowed down so that product is not degraded before it is transported [7].  196 
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 197 
In this review, we have sought to show how knowledge of the E. coli lac promoter can be 198 
exploited to produce a suite of derivative promoter fragments to cope with any situation. 199 
Previous promoter engineering had focused on altering the lac promoter -10 and -35 200 
elements to change the basal promoter expression of constructs [1, 38]. Recent advances in 201 
our understanding of transcript initiation in bacteria and its regulation now allow lac 202 
promoters to be constructed with different operator sequences to alter the induced level of 203 
expression. This is possible because, even in the presence of inducer, LacI has some affinity 204 
for its operator sequence and, thus, in the induced state the LacI repressor can still remain 205 
bound to DNA, as has been observed in single molecule studies [39].   206 
 207 
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FIGURE LEGENDS 329 
 330 
Figure 1. Transcript initiation at bacterial promoters and regulation at the lac promoter 331 
(A) Bacterial promoter elements. A sketch showing the organization of different promoter 332 
elements at a model bacterial promoter with respect to the transcript start site (+1). Elements 333 
are denoted by coloured rectangles with their consensus sequence motifs indicated. Note 334 
that bacterial promoters usually contain a selection of these elements but rarely contain all of 335 
them [40]. 336 
(B) Sketch illustrating the key interactions between different domains of the RNAP sigma 337 
and alpha subunits and different promoter elements in the initial “closed” complex at a 338 
promoter. Note that the DNA duplex remains double-stranded and that the contacts result in 339 
Sigma Domain 2 being positioned adjacent to the promoter -10 element. 340 
(C) Sketch illustrating the key interactions between different RNAP determinants and 341 
different promoter elements in the transcriptionally-competent “open” complex at a promoter. 342 
Note that the DNA duplex around position +1 is unwound, with Sigma Domain 2 making 343 
specific base contacts with the single-stranded non-template strand of the promoter -10 344 
element, thereby permitting the single-stranded template strand to enter the RNAP active 345 
site. 346 
(D) A schematic representation of the E. coli lac operon promoter. The -35 and -10 promoter 347 
elements are shown as green and yellow boxes, respectively, the lac operator sequences 348 
(O1 and O3) are red boxes and the CRP binding site is shown by inverted arrows. The 349 
position of each element is given with respect to the start site of transcription (+1). The LacI 350 
tetramer binds to the O1 and O3 operators to form a repression loop, silencing lac operon 351 
expression (-ve), whilst CRP activates transcription (+ve).  352 
 353 
 354 
Figure 2. Organisation of lac, tac and lacUV5 promoter constructs  355 
(A) The panel shows schematic representations of the lac O3O1, lacUV5 O3O1 and tac O1 356 
promoters and the important elements involved in their regulation. All numbering is in 357 
relation to the promoter transcription start (+1), which is indicated by a bent arrow. The O1 358 
and O3 operator sequences, which bind the LacI repressor, are indicated by red boxes, 359 
the -35 promoter elements by green boxes, and the CRP site, within the lacUV5 and lac 360 
promoters, is represented by inverted arrows. The plac -10 promoter element is shown as a 361 
yellow box, whilst the placUV5 and ptac consensus -10 elements are gold. The sequence of 362 
the O3, O1 and Oid operators, and the site at which different operator sequences were 363 
introduced into the tac O1, lacUV5 O3O1 and lac O3O1 promoters is shown by an arrow.  364 
(B) The panel shows the base sequence of DNA fragments carrying the lac O3O1, lacUV5 365 
O3O1 and tac O1 promoters. All promoter fragments carry the relevant sequences from -92 366 
to +38, in relation to the transcription start, and possess terminal EcoRI and HindIII sites for 367 
cloning into the lacZ expression vector, pRW50 [27]. The O1 and O3 operator sequences 368 
are highlighted in grey, CRP binding targets are underlined and the -35 and -10 promoter 369 
elements are in bold and underlined, having also been aligned to the relevant consensus 370 
sequence for each element [40]. Note that the lacUV5 promoter only differs from the wild-371 
type lac promoter by carrying a consensus -10 element (i.e. the p8A and p9A substitutions) 372 
[24].   373 
 374 
Figure 3. Expression levels of engineered ptac and plac promoter derivatives  375 
The figure illustrates measured -galactosidase activities of E. coli K-12 strain JM109 (∆lac, 376 
lacIq) cells carrying pRW50 [27, 41] containing different promoter fragments. Promoter 377 
fragments were generated using PCR and cloned into pRW50 to create lacZ transcriptional 378 
fusions, using standard techniques [27, 33]. Panels (A), (B) and (C) show the effect of 379 
introducing the O3, O1 and Oid operator sequences into the upstream region of the tac O1, 380 
lacUV5 O3O1 and lac O3O1 promoter fragments, respectively, as displayed in Figure 2. (D) 381 
The panel details the effect of introducing point mutations into the -10 and -35 elements of 382 
various lac promoter derivatives (i.e. lac O3O1, lac O1O1, lacUV5 O3O1, lacUV5 O1O1) to 383 
10 
 
improve these regions in relation to the extended -10 and -35 consensus sequences (see 384 
Figure 2) [42]. By convention, locations are labelled in relation to the plac transcript start 385 
point (+1). Note that the lac O1O1 D19 promoter carries a base pair deletion at position -19. 386 
The fold increase in expression, in comparison to the weakest promoter (lac O1O1) is 387 
indicated for each promoter in the presence of IPTG. In all panels, JM109 cells were grown 388 
in LB medium until mid-exponential phase, in the presence or absence of 1 mM IPTG. β-389 
galactosidase activities were determined using o-nitrophenyl-β-D-galactopyranose (ONPG) 390 
and a Miller protocol, as in our previous work [43], and are expressed as nmol of ONPG 391 
hydrolysed min-1 mg-1 dry cell mass. Each activity is the average of three independent 392 
determinations and the error bars represent the standard deviation of values.  393 
 394 
 395 
Figure 4. The expression of TorA-protein fusions can be set to different levels with 396 
PAR promoter constructs 397 
 (A) Expression from the PAR promoter constructs. The panel shows the β-galactosidase 398 
activities measured in the E. coli K-12 strain JM109 (∆lac, lacIq) containing the lacZ 399 
expression vector pRW50 carrying various PAR promoters. PAR promoters (PAR1 to PAR8) 400 
were selected from the various tac and lac promoters detailed in Figure 3. -galactosidase 401 
activities are expressed as nmol of ONPG hydrolysed min-1 mg-1 dry cell mass. Each activity 402 
is the average of three independent determinations and standard deviations are shown for 403 
all data points. (B) Expression of a TorA-GFP-6His protein fusion in BL21 cells (Novagen), 404 
using pGFP-TorA based vectors [30].  PAR promoters, PAR4 to PAR6 and PAR8 were 405 
introduced into the low-copy-number vector pGFP-TorA, such that each promoter drives the 406 
expression of a torA-gfp-6his fusion. Note that pGFP-TorA is a derivative of expression 407 
vector pEXT22 [44], which has been included as an empty vector control. (C) Expression of 408 
a TorA-hGH-6His protein fusion in BL21 cells, using pHAK1 based vectors [31].  PAR 409 
promoters, PAR5 to PAR8 were introduced into the high-copy-number vector pHAK1 such 410 
that each promoter drives the expression of a torA-hGH-6his fusion. Note that the torA signal 411 
sequence directs the GFP-6His and hGH-6His moieties to the Tat translocon for periplasmic 412 
targeting [7, 30, 31]. Cells were grown in LB medium until an OD600 of ~0.4 when RPP was 413 
induced by the addition of 1 mM IPTG for 3 hrs. In (B) and (C) expression of TorA-GFP-6His 414 
and TorA-hGH-6His was analysed by Western blotting (upper panel), using either anti-GFP 415 
antibody (Sigma) or polyclonal anti-hGH antibody, respectively, and a Coomassie blue 416 
strained SDS-PAGE gel (lower panel), using normalised total cell protein from BL21 cells, as 417 
detailed in [45]. Samples were calibrated by loading Page Ruler Plus prestained markers 418 
(Thermo Scientific). Note that, in the Western blot in panel (B), all lanes were from the same 419 
blot and have only been separated to aid presentation of the data. 420 
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